Richard M Glickman Net Worth

The estimated Net Worth of Richard M Glickman is at least $305 mil dollars as of 24 April 2024. Richard Glickman owns over 3,750 units of Essa Pharma Inc stock worth over $305,274 and over the last 4 years Richard sold EPIX stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Richard Glickman EPIX stock SEC Form 4 insiders trading

Richard has made over 1 trades of the Essa Pharma Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Richard exercised 3,750 units of EPIX stock worth $18,375 on 24 April 2024.

The largest trade Richard's ever made was exercising 3,750 units of Essa Pharma Inc stock on 24 April 2024 worth over $18,375. On average, Richard trades about 938 units every 0 days since 2020. As of 24 April 2024 Richard still owns at least 43,240 units of Essa Pharma Inc stock.

You can see the complete history of Richard Glickman stock trades at the bottom of the page.

What's Richard Glickman's mailing address?

Richard's mailing address filed with the SEC is C/O ESSA PHARMA INC., 999 WEST BROADWAY, SUITE 720, VANCOUVER, A1, V5Z 1K5.

Insiders trading at Essa Pharma Inc

Over the last 4 years, insiders at Essa Pharma Inc have traded over $924,311 worth of Essa Pharma Inc stock and bought 3,342,445 units worth $15,321,880 . The most active insiders traders include Growth N Vbb Biotech Ag Bio..., Franklin M Berger, eMarella Thorell. On average, Essa Pharma Inc executives and independent directors trade stock every 57 days with the average trade being worth of $1,108,300. The most recent stock trade was executed by Peter Virsik on 9 September 2024, trading 694 units of EPIX stock currently worth $4,164.

What does Essa Pharma Inc do?

as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in our approach. we're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical company.

Complete history of Richard Glickman stock trades at Essa Pharma Inc

Essa Pharma Inc executives and stock owners

Essa Pharma Inc executives and other stock owners filed with the SEC include:

• Dr. David Ross Parkinson M.D.,
  Pres, CEO & Director
• Peter A. Virsik M.B.A., M.S.,
  Exec. VP & COO
• Dr. Alessandra Cesano M.D., Ph.D.,
  Chief Medical Officer
• David S. Wood C.M.A., CPA, M.B.A., MBA, CPA, CMA,
  Chief Financial Officer
• Neil Thapar,
  Exec.
• Loleta Harris,
  Exec.
• Leah Dimascio,
  Exec.
• Erin Rudsinski,
  Exec.
• Erica Osbourne,
  Exec.
• Chandtip Chandhasin,
  Exec.
• Scott Requadt,
  
• Philip W. Kantoff,
  
• Lauren Merendino,
  
• John Alexander Martin,
  
• Richard M Glickman,
  
• Gary Sollis,
  
• Marella Thorell,
  
• Sanford S Zweifach,
  
• Growth N Vbb Biotech Ag Bio...,
  
• David Ross Parkinson,
  Chief Executive Officer
• Peter Virsik,
  Chief Operating Officer
• Ari David Brettman,
  Director
• Franklin M Berger,
  
• David S. Wood,
  Chief Financial Officer